Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
02/2003
02/25/2003US6525052 Compounds useful as reversible inhibitors of cysteine proteases
02/25/2003US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
02/25/2003US6525044 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome.
02/25/2003US6525000 N-aminoureas are reacted with formaldehyde to give methyleneimino ureas, cyclizing these to give tetrahydro-4H-1,3,4-oxa(or thia)diazines, and cyclizing the fused triazoles using phosgene; herbicides
02/25/2003US6524446 Process for synthesis of a porphyrin compound using a molecular sieve catalyst under microwave irradiation
02/25/2003US6524382 Pigmented vitreous material
02/20/2003WO2003014075A2 Novel gamma secretase inhibitors
02/20/2003WO2003013571A1 Peptidomimetics of biologically active metallopeptides
02/20/2003WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits
02/20/2003WO2003013541A1 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
02/20/2003WO2002072585A3 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics
02/20/2003WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof
02/20/2003WO2002024635A3 Aminoalcohol derivatives
02/20/2003US20030036660 As chemical intermediate
02/20/2003US20030036652 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4'-piperidines
02/20/2003US20030036545 (6-aryl-pyrrolo(2,3-d)pyrimidin-4-yl)amine derivatives; treating Parkinson's disease and diseases associated with locomotor activity, vasodilation, platelet inhibition, neutrophil superoxide generation, cognitive disorders, etc.
02/20/2003US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
02/20/2003US20030036473 Catalysts and methods for catalytic oxidation
02/20/2003CA2462200A1 Peptidomimetics of biologically active metallopeptides
02/20/2003CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists
02/19/2003EP1283839A1 Adenosine a2a receptor antagonists
02/19/2003EP1165559B1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
02/19/2003EP1056749B1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS
02/19/2003EP1005473B1 Novel organometallic compound, preparation method thereof and process for polymerization of olefins by means of a catalyst composition including the organometallic compound
02/19/2003EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
02/19/2003CN1398266A N-(5,7-dimethoxy[1,2,4] triazolo[1,5-a]pyrimidin-2-yl) arylsulfonamide compounds and their use as herbicides
02/19/2003CN1397551A N-([1,2,4]triazoleo azine group) benzene sulfonamide and pyridine sulfamide compound and their use as herbicide
02/19/2003CN1101817C Process for prepn. of tetrazamacrocycles
02/18/2003WO2002016329A1 Novel phenylalanine derivatives
02/18/2003US6521757 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
02/18/2003US6521636 Imidazo-pyridines as corticotropin releasing factor antagonists
02/18/2003US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity
02/18/2003US6521612 Antibiotic compounds
02/13/2003WO2003011872A1 Platelet adp receptor inhibitors
02/13/2003WO2003011866A1 Porphyrin-metal complexes and oxygen infusions containing the same
02/13/2003WO2003011865A1 Novel materials for selective trapping of carbon monoxide
02/13/2003WO2003011824A1 Bicyclic modulators of androgen receptor function
02/13/2003WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes
02/13/2003WO2003011228A2 Purification and crystalline forms of zaleplon
02/13/2003WO2003011222A2 Thrombin inhibitors
02/13/2003WO2002088125A3 Triazolopyrimidines having a fungicidal effect
02/13/2003WO2002076988A3 Tert. alkylphenoxy substituted polycyclic compounds
02/13/2003WO2002059082A8 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
02/13/2003WO2002037927A3 Compounds and methods for promoting smoking cessation
02/13/2003US20030032799 For cancer treatment
02/13/2003US20030032647 Aromatic nitrogen-containing 6-membered cyclic compounds
02/13/2003US20030032623 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis.
02/13/2003US20030031676 Conjugate compounds for treating atheroma and other diseases
02/13/2003US20030028975 For dyeing hair
02/13/2003CA2468925A1 Platelet adp receptor inhibitors
02/13/2003CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones
02/13/2003CA2453751A1 Purification and crystalline forms of zapelon
02/12/2003EP1283058A1 Agents for preventing or ameliorating insulin resistance and/or obesity
02/12/2003EP1282630A1 Hydroxylamine esters as polymerization initiators
02/12/2003EP1282624A1 Crf receptor antagonists and methods relating thereto
02/12/2003EP1282623A1 Pyrazolo-triazine derivatives as ligands for gaba receptors
02/12/2003EP1023294B1 Carbapenem derivatives and a preparation method thereof
02/12/2003EP0980374B1 Phosphodiesterase 4-inhibiting diazepinoindolones
02/12/2003EP0937078B1 Tricyclic carbapenem compounds
02/12/2003CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
02/12/2003CN1396922A Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid
02/12/2003CN1396198A Bulk coloured high polymer organic material containing pyrimido-pteridine or its mixture
02/12/2003CN1396165A Zilpaterol hydrochcoride monohydrate
02/12/2003CN1101397C Preparation of beta-methyl carbepenem intermediate
02/12/2003CN1101189C Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as active ingredient
02/12/2003CN1101188C use of green porphyrins in manufacture of medicament in treatment of atherosclerosis without purposeful irradiation of porphyrin derivatives
02/11/2003US6518427 Compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of these compounds. They are also rapidly converted back to the parent amines in vivo, making them useful as prodrugs of the parent amines.
02/11/2003US6518426 Pyrimidine derivatives and methods of making and using these derivatives
02/11/2003US6518423 Benzopiperidine derivatives
02/11/2003US6518286 Compounds
02/11/2003US6518277 Disrupting leukocyte function
02/11/2003US6518273 2-aryl indole derivative as antagonists of tachykinins
02/11/2003US6518270 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
02/11/2003US6518267 Protease inhibitors
02/11/2003US6518222 N-([1,2,4] triazoloazinyl) thiophenesulfonamide compounds and their use as herbicides
02/11/2003CA2253678C Keratin fibre dye compositions, containing 3-amino pyrazolo-¬1,5-a|- pyrimidines, dyeing technique, new 3-amino pyrazolo-¬1,5-a|-pyrimidines and their method of preparation
02/11/2003CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones
02/10/2003WO2002014322A1 PORPHYRIN COMPOUNDS CONSISTING OF PORPHYRIN RINGS FUSED IN A SINGLE DIRECTION BY THREE BONDS, I.E., ONE MESO-MESO CARBON BOND AND TWO β-β CARBON BONDS AND PROCESS FOR THEIR SYNTHESIS
02/06/2003WO2003010158A1 Novel compounds
02/06/2003WO2003009852A1 Tyrosine kinase inhibitors
02/06/2003WO2003009842A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/06/2003WO2003009809A2 Cancer treatment with gö6976 and its related compounds
02/06/2003WO2003009687A1 7-amino triazolopyrimidines for controlling harmful fungi
02/06/2003WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
02/06/2003WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors
02/06/2003WO2002039953A3 Texaphyrin coordination compounds and uses thereof
02/06/2003WO2001037629A8 High surface microporous materials which are active in oxidation reactions. tiq-6 and metiq-6
02/06/2003US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer
02/06/2003US20030027824 Pyrazolopyrimidinones for the treatment of female sexual dysfunction
02/06/2003US20030027815 10-(4-cyclohexylbenzoyl)-10,11-dihydro-5H-pyrrolo(2,1-c)(1,4)b enzodiazepine derivatives, useful for suppression of disorders which may be remedied or alleviated by oxytocin antagonist activity, including premature labor
02/06/2003US20030027814 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases
02/06/2003US20030027808 Imidazoly-5-yl)methyl-2-quinolinone derivatives, together with platinum coordination compound selected from cisplatin or carboplatin; useful as anticarcinogenic agent
02/06/2003US20030027807 Vitronectin receptor antagonists, their preparation and their use
02/06/2003CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor
02/06/2003CA2454542A1 7-amino triazolopyrimidines for controlling harmful fungi
02/06/2003CA2454150A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/05/2003EP1281711A1 Interstrand crosslinking agents for dna and compounds therefor
02/05/2003EP1280805A1 Novel imidazotriazinones and the use thereof
02/05/2003EP1280780A2 Asymmetric synthesis of piperazic acid and derivatives thereof
02/05/2003EP1280771A2 Novel prodrugs von 6-hydroxy-2,3-dihydro-1h-indoles, 5-hydroxy-1,2-dihydro-3h-pyrrolo 3,2-e]indoles and 5-hydroxy-1,2-dihydro-3h-benzo(e)indoles as well as of 6-hydroxy-1,2,3,4-tetrahydro-benzo f]quinoline derivatives for use in selective cancer therapy